Company Filing History:
Years Active: 2021
Title: The Innovations of Joshua McElwee
Introduction
Joshua McElwee is an accomplished inventor based in Jamaica Plains, MA (US). He has made significant contributions to the field of genetics, particularly in relation to CRTH2 receptor antagonists. His work focuses on identifying genetic markers that can help tailor treatments for patients.
Latest Patents
Joshua McElwee holds a patent for "Genetic markers associated with response to CRTH2 receptor antagonists." This invention provides genetic markers located on human chromosome 1 that are associated with a beneficial response to CRTH2 receptor antagonists. These markers are instrumental in identifying patients who are most likely to benefit from treatment with CRTH2 receptor antagonist compositions and drug products. The patent outlines methods for treating patients with diseases that are susceptible to CRTH2 receptor antagonists and for selecting the most appropriate therapy for such patients. He has 1 patent to his name.
Career Highlights
Joshua McElwee is currently employed at Merck Sharp & Dohme Corp., where he continues to advance his research and innovations. His work at this prominent pharmaceutical company allows him to collaborate with other experts in the field and contribute to the development of new therapies.
Collaborations
Some of his notable coworkers include Gregory J Opiteck and Peggy H Wong. Their collaboration enhances the research environment and fosters innovation within the company.
Conclusion
Joshua McElwee's contributions to the field of genetics and his innovative patent on CRTH2 receptor antagonists highlight his role as a significant inventor. His work not only advances scientific understanding but also has the potential to improve patient care through personalized medicine.